Amikacin for Ventilator Associated Pneumonia (AMIKINHAL trial) The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000 Preventive bundle approach decreases the incidence of ventilator associated pneumonia in newborn infants Journal of Perinatology Criteria used for the diagnosis of VAP. Adapted from the European Download Scientific Diagram Prevention of ventilator associated pneumonia HKMJ